Calprotectin and Ischemia Modified Albumin Serum to Measure Disease Activity in Behçet's Disease
NCT ID: NCT05868538
Last Updated: 2023-05-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2019-04-01
2023-03-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Endocan Serum Levels in Patients With Behcet Disease
NCT03853135
Understanding the Role of Oral Microbiota in Behçet's Disease (BEHCETBIOT)
NCT04959435
Pan-immune-inflammation Value (PIN) in Behçet's Disease and Its Correlation With Disease Activity
NCT06729112
Behçet and LDH/Albumin
NCT06276829
How Sirtuin Levels Change During Behçet Disease
NCT06266247
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients
Serum calprotectin and IMA concentrations
Serum calprotectin and IMA concentrations were compared among active BD cases, inactive BD cases and control subjects.
control
Serum calprotectin and IMA concentrations
Serum calprotectin and IMA concentrations were compared among active BD cases, inactive BD cases and control subjects.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Serum calprotectin and IMA concentrations
Serum calprotectin and IMA concentrations were compared among active BD cases, inactive BD cases and control subjects.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mansoura University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sherin Mashaly, MD
Role: STUDY_CHAIR
Professor of Rheumatology and Rehabilitation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mansoura University Hospital
Al Mansurah, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R.22.10.1905 - 2022/10/17
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.